Latest Updates

Evaluation of a Soft Tissue Mass in the Extremity or Trunk

Dale Han, MD, Daniel C Thomas, MD, MPH
    • Multidisciplinary planning and use of core-needle biopsy for diagnosis of soft tissue sarcoma
    • Impact of tumor grade and histologic subtype on outcomes for soft tissue sarcoma
    • Development of molecular diagnostic testing for soft tissue sarcoma

Complications of Arteriovenous Hemodialysis Access

Thomas S. Huber, MD, PhD

    Kidney Neoplasia

    Pablo M Barrios, Carlos H Barrios, MD, Andre P Fay, MD, Fábio A B Schutz, MD
      • The incidence of renal cell carcinoma (RCC) is rising worldwide. Incidental detection of small renal tumor accounts for more than 50% of all new renal masses.
      • RCC is a very heterogeneous disease, and different histologic subtypes have been recognized. The understanding of the biology underlying the different tumor types arising from the kidney epithelium has opened new avenues to better define prognosis, to develop biomarkers, and to individualize therapies across the different cancer subtypes.
      • Management of kidney tumors has advanced significantly in the last few decades. A multidisciplinary approach is critical in the decision-making process.
      • Recently, the new immunotherapy approaches have led to renewed hope in the treatment of metastatic RCC.

    Breast Reconstruction

    Eliana F R Duraes, MD, Graham S Schwarz, MD, FACS
      • Skin- and nipple-preserving mastectomy
      • Improvement in implant device design and materials
      • Microsurgical/perforator flap reconstruction
      • Intraoperative perfusion assessment
      • Fat grafting

    Evaluation of Intra-abdominal and Retroperitoneal Soft Tissue Masses

    Jeffrey M Farma, MD, FACS, Neha Goel, MD
      • Initial evaluation of intra-abdominal and retroperitoneal masses including laboratory studies, radiographic imaging, and genetic workup
      • Discussion of when and how biopsies should be performed for intra-abdominal and retroperitoneal masses
      • Discussion of management of complex sarcomas and when neoadjuvant chemotherapy or radiotherapy should be considered

    Breast Reconstruction

    Eliana F R Duraes, MD, Graham S Schwarz, MD, FACS
      • Skin- and nipple-preserving mastectomy
      • Improvement in implant device design and materials
      • Microsurgical/perforator flap reconstruction
      • Intraoperative perfusion assessment
      • Fat grafting

    Evaluation of Intra-abdominal and Retroperitoneal Soft Tissue Masses

    Jeffrey M Farma, MD, FACS, Neha Goel, MD
      • Initial evaluation of intra-abdominal and retroperitoneal masses including laboratory studies, radiographic imaging, and genetic workup
      • Discussion of when and how biopsies should be performed for intra-abdominal and retroperitoneal masses
      • Discussion of management of complex sarcomas and when neoadjuvant chemotherapy or radiotherapy should be considered

    Medical Futility

    Jacob A Blythe, MA, MD, Stephanie Harman, MD
      • Medical futility has developed as an ethical construct to approach patient/family requests for clinical interventions that are not medically effective in achieving their intended goal and creates recourse for clinicians to address these requests.
      • Several states now have legislation that govern medical futility that offers protections for both clinicians and patients and families.
      • A process-based approach incorporating the concept of “potentially inappropriate” care has now been established in society guidelines promoting a shared decision-making approach and aligning the goals of clinicians and patients and families.
    « Previous | Next »
    Updates per yearSpecialty updatesNumber of sections